Literature DB >> 30191028

Epidemiology and surgical management of intrahepatic cholangiocarcinoma.

Han Zhang1, Feng Shen1, Jun Han1, Yi-Nan Shen1, Guo-Qiang Xie1, Meng-Chao Wu1, Tian Yang1.   

Abstract

Intrahepatic cholangiocarcinoma (ICC) is a rare hepatobiliary malignancy arising from the epithelial cells of the intrahepatic bile ducts. The increased incidence of ICC worldwide may reflect both a true increase and the earlier detection of the disease. Despite the advances in modern surgical care, the curative chance for ICC remained suboptimal: tumor-free margins are hard to achieve due to tumor locations, and technical challenges and recurrence, either local or distant, may hamper the resectability in a large number of patients. Lymph node involvement and vascular invasions are considered negative predictive factors for survival of ICC patients. This review discusses the epidemiology, risk factors and surgical management of ICCs, and mainly focuses on outcomes and factors associated with surgical treatment.

Entities:  

Keywords:  epidemiology; intrahepatic cholangiocarcinoma; risk factor; surgical resection

Year:  2015        PMID: 30191028      PMCID: PMC6095184          DOI: 10.2217/hep.15.34

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN: 2045-0923


  74 in total

1.  Extended resection for intrahepatic cholangiocarcinoma in Japan.

Authors:  M Yamamoto; K Takasaki; T Yoshikawa
Journal:  J Hepatobiliary Pancreat Surg       Date:  1999

Review 2.  Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment.

Authors:  M F Chen
Journal:  J Gastroenterol Hepatol       Date:  1999-12       Impact factor: 4.029

Review 3.  Multidisciplinary approaches to intrahepatic cholangiocarcinoma.

Authors:  Shishir K Maithel; T Clark Gamblin; Ihab Kamel; Celia Pamela Corona-Villalobos; Melanie Thomas; Timothy M Pawlik
Journal:  Cancer       Date:  2013-08-20       Impact factor: 6.860

4.  Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

Authors:  Juan Valle; Harpreet Wasan; Daniel H Palmer; David Cunningham; Alan Anthoney; Anthony Maraveyas; Srinivasan Madhusudan; Tim Iveson; Sharon Hughes; Stephen P Pereira; Michael Roughton; John Bridgewater
Journal:  N Engl J Med       Date:  2010-04-08       Impact factor: 91.245

5.  Risk factors for early bilirubinemia after major hepatectomy for perihilar cholangiocarcinoma with portal vein embolization.

Authors:  Yoshihiro Sakamoto; Kazuaki Shimada; Satoshi Nara; Minoru Esaki; Takahiro Kajiwara; Yasuaki Arai; Tsuyoshi Sano; Junji Yamamoto; Tomoo Kosuge
Journal:  Hepatogastroenterology       Date:  2010 Jan-Feb

Review 6.  Intrahepatic cholangiocarcinoma: macroscopic type and stage classification.

Authors:  Susumu Yamasaki
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

7.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

8.  Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.

Authors:  Hashem B El-Serag; Eric A Engels; Ola Landgren; Elizabeth Chiao; Louise Henderson; Harshinie C Amaratunge; Thomas P Giordano
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

9.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.

Authors:  Tania M Welzel; Barry I Graubard; Hashem B El-Serag; Yasser H Shaib; Ann W Hsing; Jessica A Davila; Katherine A McGlynn
Journal:  Clin Gastroenterol Hepatol       Date:  2007-08-06       Impact factor: 11.382

10.  Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?

Authors:  Shahid A Khan; Shireen Emadossadaty; Nimzing G Ladep; Howard C Thomas; Paul Elliott; Simon D Taylor-Robinson; Mireille B Toledano
Journal:  J Hepatol       Date:  2011-12-13       Impact factor: 25.083

View more
  3 in total

1.  Prognostic value of multiple epithelial mesenchymal transition-associated proteins in intrahepatic cholangiocarcinoma.

Authors:  Xiangguo Tian; Zhixin Cao; Qian Ding; Zhen Li; Chunqing Zhang
Journal:  Oncol Lett       Date:  2019-06-24       Impact factor: 2.967

2.  Efficacy of fluoxetine for anorexia nervosa caused by chemotherapy in patients with cholangiocarcinoma.

Authors:  Lin-Qi Guo; Hua-Wei Sun; Chun-Ye Zhang; Yao Feng; Xin-Li Teng; Yi-Kun Qu
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

3.  Transcriptomic analysis and identification of prognostic biomarkers in cholangiocarcinoma.

Authors:  Hanyu Li; Junyu Long; Fucun Xie; Kai Kang; Yue Shi; Weiyu Xu; Xiaoqian Wu; Jianzhen Lin; Haifeng Xu; Shunda Du; Yiyao Xu; Haitao Zhao; Yongchang Zheng; Jin Gu
Journal:  Oncol Rep       Date:  2019-09-17       Impact factor: 3.906

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.